EpiQMAx provides a service for the sensitive detection and quantification of proteins and histone epigenetic modifications. Their proprietary kit, coupled with mass spectrometry, enables fast analysis with low sample requirements for pharmaceutical companies, clinics, and scientific labs. Customers receive clear, interactive visualizations of their results through accessible online reports.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for detecting and quantifying histone modifications and proteins often require large sample inputs and lack the sensitivity needed for precise epigenetic data analysis. Pharmaceutical companies, clinics, and scientific labs need more efficient and accurate tools to measure epigenetic marks.
Solution
EpiQMAx offers a mass spectrometry-based service for the detection and quantification of proteins and histone epigenetic modifications. Their workflow is designed for pharmaceutical companies, clinics, and scientific labs, providing a streamlined solution for epigenetic data acquisition. The technology requires minimal sample input while delivering results with high sensitivity. EpiQMAx also provides clear and interactive visualizations for data analysis, enabling users to easily interpret and examine their results.
Target Audience
EpiQMAx serves pharmaceutical companies, clinics, and scientific labs seeking precise epigenetic data.
Features
- Mass spectrometry-based detection and quantification of histone modifications and proteins
- High sensitivity measurements
- Low sample input requirements
- Interactive visualizations for data analysis